Nome Químico: 2-(((4-Cyanophenyl)amino)methyl)-1-methyl-1H-benzo[d]imidazole-5-carboxylic acid
Sorrisos: O=C(C1=CC=C(N(C)C(CNC2=CC=C(C#N)C=C2)=N3)C3=C1)O
Inchi: InChI=1S/C16H17N5O2/c17-15(18)10-1-5-12(6-2-10)20-9-14(22)21-13-7-3-11(4-8-13)16(19)23/h1-8,20H,9H2,(H3,17,18)(H2,19,23)(H,21,22)
Novel method for separation and quantification of potential impurities by RP-HPLC from KSM stage to API stage of dabigatran mesylate
By Jhansi, T. Naga; Nagaraju, R.; Kumar, D. Jaya Deep; Rao, G. Nageswara
From International Journal of Pharmaceutical Sciences and Research (2021), 12(3), 1762-1779
Development and Validation of RP-UPLC Method for the Determination of Process and Degradant Impurities Present in Dabigatran Etexilate Mesylate Capsules Using High Strength Silica-T3 Sorbent Column
By Mantena, Bhaskara P. V.; Rao, Sumathi V.; Suryakala, D.; Ramakrishna, K.; Srikanth Reddy, R.
From Analytical Chemistry Letters (2016), 6(5), 595-611
Determination of dabigatran etexilate mesylate by HPLC
By Jia, Ling-xiao; Tang, Lei; Zhang, Shu-ting; Song, Rui-zhi; Gao, Zhan-wen
From Shipin Yu Yaopin (2015), 17(3), 195-197